DUE-An Essential Tool to Achieve QUM

Abstract

The Australian Journal of Hospital PharmacyVolume 30, Issue 6 p. 251-252 EditorialFree Access DUE-An Essential Tool to Achieve QUM Jonathan GA Dartnell BPharm, MPS, PhD, Jonathan GA Dartnell BPharm, MPS, PhD Convenor, Production Manager jdartnell@tg.com.au ASCEPT DUE Network Therapeutic Guidelines Limited Level 2, 55 Flemington Rd, North Melbourne Vic. 3051Search for more papers by this authorSue W Kirsa BPharm, Sue W Kirsa BPharm Grad Dip Hosp Pharm Chair, Chair, Victorian Drug Usage Evaluation Group Senior DUE Pharmacist sue.kirsa@armc.org.au Austin and Repatriation Medical Centre, Studley Road, Heidelberg, Vic. 3084Search for more papers by this author Jonathan GA Dartnell BPharm, MPS, PhD, Jonathan GA Dartnell BPharm, MPS, PhD Convenor, Production Manager jdartnell@tg.com.au ASCEPT DUE Network Therapeutic Guidelines Limited Level 2, 55 Flemington Rd, North Melbourne Vic. 3051Search for more papers by this authorSue W Kirsa BPharm, Sue W Kirsa BPharm Grad Dip Hosp Pharm Chair, Chair, Victorian Drug Usage Evaluation Group Senior DUE Pharmacist sue.kirsa@armc.org.au Austin and Repatriation Medical Centre, Studley Road, Heidelberg, Vic. 3084Search for more papers by this author First published: 01 December 2000 https://doi.org/10.1002/jppr2000306251Citations: 1AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Campbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sandercock P, Spiegelhalter D. et al. Framework for design and evaluation of complex interventions to improve health. BMJ 2000; 321: 694– 6. 2Fellows L, Hughes JD. A survey of drug audit practices and promotion of quality prescribing in Australian hospitals with a focus on psychotropic drugs. Aust J Hosp Pharm 2000; 30: 196– 201. 3Bowman L. Drug use evaluation is DUE: healthcare utilization evaluation is over-DUE. Hosp Pharm 1996; 31: 347– 53. 4Kaye KI. DUE: arose by any other name… Aust J Hosp Pharm 2000; 30: 27982. 5Robertson MB, Dartnell JGA, Korman TM, on behalf of the Victorian Drug Usage Evaluation Group. Vancomycin and teicoplanin use in Victorian hospitals. Med J Aust 1999; 171: 127– 31. 6Lyon D, Millar JA. Improvement in antibiotic prescribing at a regional hospital in Western Australia after implementation of national guidelines and external review [abstract]. Proc Aust Soc Clin Exp Pharmacol Toxicol 1999; 6: 22. 7 The Society of Hospital Pharmacists of Australia Committee of Specialty Practice in Drug Usage Evaluation. SHPA standards of practice for drug usage evaluation in Australian hospitals. Aust J Hosp Pharm 1996; 26: 240– 6. 8 The Society of Hospital Pharmacists of Australia Committee of Specialty Practice in DUE. Australian drug usage evaluation starter kit. South Melbourne: SHPA; 1998. 9Nolan AM, Norquay CA, Dartnell JG, Harvey KJ. Electronic prescribing and computer-assisted decision support systems. Med J Aust 1999; 171: 541– 3. 10Misan G. Hospital pharmacy data. In: D Walker, editor. Australian national pharmacoepidemiological database seminar, 1997. Adelaide: Australian Pre-scriber; 1997: 18– 20. 11Harvey K. Therapeutic guidelines - the way ahead. Australian Prescriber 1993; 16 (suppl. 3): 13– 16. Citing Literature Volume30, Issue6December 2000Pages 251-252 ReferencesRelatedInformation